Company intelligence / Profile preview

VascularFX

San Antonio, Texas, USA

Ownership: Private
Development stage: Other

Overview

VascularFX was a medical device company focused on developing innovative solutions for vascular access and interventional procedures. The company's primary technology centered on specialized catheter systems designed to improve the efficiency and safety of vascular interventions. Its products were aimed at addressing challenges in peripheral artery disease (PAD) and other vascular conditions requiring precise access. In 2010, the company was acquired by C. R. Bard, a global leader in medical technology, which integrated VascularFX's portfolio into its vascular access division.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on VascularFX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VascularFX.

Explore the full profile